Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 9Phase 1 3Phase 4 1Phase 3 1Phase 1/2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Prostatic Hyperplasia 1Disease 1

Interventions

Docetaxel 43enzalutamide 31Prednisone 25Abiraterone Acetate 24Magnetic Resonance Spectroscopy 18abiraterone 15pembrolizumab 14bicalutamide 14Radiotherapy 14Cyclophosphamide 13darolutamide 12Leuprolide 12Goserelin 12apalutamide 10Ipilimumab 10olaparib 9Specimen Handling 9Radiosurgery 9Radiation 9Injections 9Biopsy 9Pluvicto 8Paclitaxel 8Radiotherapy, Intensity-Modulated 7Carboplatin 7sargramostim 6fludarabine 6cabazitaxel 6Sirolimus 6Nivolumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Prostatic Neoplasms × Prostatectomy × Clear all
NCT07054346 2026-04-01

LUTACT

University of California, San Francisco

Phase 1 Recruiting
45 enrolled
Genitourinary

Disease, Prostatic Neoplasms

NCT02572284 2023-01-19

Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
7 enrolled
Genitourinary

Prostatic Neoplasms

NCT02916537 2017-11-06

A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057

Cancer Targeted Technology

Phase 1 Completed
20 enrolled
Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡